Two corrupt companies were in rocky financial territory just a few weeks ago. Now, with concerns over a global monkeypox outbreak being hyped by media and global health organizations alike, the worries – and sins – of these two firms are quickly being forgotten.
In recent days, concern over a global outbreak of monkeypox, a mild disease related to smallpox and chickenpox, has been hyped in the media and health ministries around the world, even prompting an emergency meeting at the World Health Organization (WHO). For some, fears have centered around monkeypox being the potential “next pandemic” after Covid-19. For others, the fear is that monkeypox will be used as the latest excuse to further advance draconian biosecurity policies and global power grabs.
Regardless of how the monkeypox situation plays out, two companies are already cashing in. As concern over monkeypox has risen, so too have the shares of Emergent Biosolutions and SIGA Technologies. Both companies essentially have monopolies in the US market, and other markets as well, on smallpox vaccines and treatments. Their main smallpox-focused products are, conveniently, also used to protect against or treat monkeypox as well. As a result, the shares of Emergent Biosolutions climbed 12% on Thursday, while those of SIGA soared 17.1%.
https://unlimitedhangout.com/2022/05/investigative-reports/monkeypox-fears-may-rescue-endangered-corporations
Whitney Webb Archive
https://earthnewspaper.com/category/whitney-webb
Subscribe To The EarthNewspaper.com Newsletter
https://EarthNewspaper.com/Subscribe
Support Honest, Independent, And Ad-Free Media
https://EarthNewspaper.com/Donate